4 unknown, 1 recruiting. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Unknown 4, Recruiting 1 |
Follow Hypertensive Crisis: new trials by email Literature Review of Hypertensive Crisis trials Research Report on Hypertensive Crisis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome Soliris®, Renin angiotensin system blockers - Hypertensive Emergency-associated Hemolytic Uremic Syndrome | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 66 | 2023-11-09 | 2024-01-05 |
| a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency QLG2071, Cleviprex® - Hypertensive Emergency | Phase 3 | Unknown | Qilu Pharmaceutical (Hainan) Co., Ltd. | 378 | 2023-07-15 | 2023-06-28 |
| A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency Clevidipine Butyrate Injectable Emulsion, Cleviprex® - Hypertensive Emergency | Phase 3 | Unknown | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 398 | 2023-05-01 | 2023-03-24 |
| Clinical Study of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergency and Sub-emergency This is a randomized, single-blind, parallel-controlled clinical study with the original research clevidipine butyrate injection as the positive control drug, which is an equivalence test. - Hypertensive Emergency | Phase 3 | Unknown | Shenzhen People's Hospital | 10 | 2021-10-11 | 2021-09-14 |
| Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies Clevidipine Butyrate Injection, Ncardipine Hydrochloride Injection - Hypertensive Emergency | Phase 3 | Unknown | Nanjing Yoko Biomedical Co., Ltd. | 262 | 2020-07-27 | 2020-12-17 |
Acute Kidney Injury (1) · Atypical Hemolytic Uremic Syndrome (1) · Kidney Failure, Chronic (1)
Cardiovascular Diseases (5) · Hypertension (5) · Vascular Diseases (5) · Anemia (1) · Anemia, Hemolytic (1) · Blood Platelet Disorders (1) · Chronic Disease (1) · Cytopenia (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemolytic-Uremic Syndrome (1) · Kidney Diseases (1)
clevidipine (2) · Single-Blind Method (1) · eculizumab (1)
Assistance Publique - Hôpitaux de Paris (1) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (1) · Nanjing Yoko Biomedical Co., Ltd. (1) · Qilu Pharmaceutical (Hainan) Co., Ltd. (1) · Shenzhen People's Hospital (1)
China (2) · France (1)
Changsheng Ma (1) · Yuguo Chen (1)